These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8357203)

  • 21. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH; Barchan D; Souroujon MC; Fuchs S
    J Immunol; 2000 Oct; 165(7):3599-605. PubMed ID: 11034361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients.
    Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T
    Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T cell response to the human acetylcholine receptor alpha subunit in myasthenia gravis. A study with synthetic peptides.
    Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
    J Immunol; 1990 Feb; 144(4):1276-81. PubMed ID: 1968078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of acetylcholine receptor-specific suppression. An in vitro model of antigen-specific immunosuppression in myasthenia gravis.
    Bogen S; Mozes E; Fuchs S
    J Exp Med; 1984 Jan; 159(1):292-304. PubMed ID: 6198424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
    Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
    J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of immunological fine-specificity on the induction of experimental myasthenia gravis.
    Krolick KA; Thompson PA; Zoda TE; Yeh TM
    Ann N Y Acad Sci; 1993 Jun; 681():179-97. PubMed ID: 7689305
    [No Abstract]   [Full Text] [Related]  

  • 30. A new mouse model of autoimmune ocular myasthenia gravis.
    Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis.
    Sato T; Ishigaki Y; Komiya T; Tsuda H
    Ann N Y Acad Sci; 1988; 540():554-6. PubMed ID: 3061349
    [No Abstract]   [Full Text] [Related]  

  • 32. T cells in myasthenia gravis specific for embryonic acetylcholine receptor.
    Protti MP; Manfredi AA; Howard JF; Conti-Tronconi BM
    Neurology; 1991 Nov; 41(11):1809-14. PubMed ID: 1682852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative responses to acetylcholine receptor peptides in myasthenia gravis.
    Berrih-Aknin S; Cohen-Kaminsky S; Neumann D; Bach JF; Fuchs S
    Ann N Y Acad Sci; 1988; 540():504-5. PubMed ID: 2462824
    [No Abstract]   [Full Text] [Related]  

  • 37. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
    Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
    Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.
    Hohlfeld R; Toyka KV; Tzartos SJ; Carson W; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5379-83. PubMed ID: 2955417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmapheresis changes lymphocyte subsets in myasthenia gravis.
    Fujishita S; Motomura M; Ohishi K; Kanazawa H; Shibuya N
    Prog Clin Biol Res; 1990; 337():297-9. PubMed ID: 2141172
    [No Abstract]   [Full Text] [Related]  

  • 40. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.